PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

PAR. SP, page-653

  1. 628 Posts.
    lightbulb Created with Sketch. 114
    The problem with that argument@Nike77 is that although I'm sure you are right, that is something that could and should have been anticipated and allowed for in their timeline, surely. I'm now more interested in their FDA interactions that were to happen this month. Maybe we will be pummelled with announcements soon!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.